Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

  Molecular role of Bruton's Tyrosine Kinase (BTK) in the NLRP3 Inflammasome


   Interfaculty Institute of Cell Biology, Department of Immunology

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities
  Prof Alexander Weber  No more applications being accepted  Funded PhD Project (Students Worldwide)

About the Project

Topic

The NLRP3 inflammasome is a multi-protein complex driving inflammation upon exogenous and endogenous (sterile) insults during infection, tissue damage or cellular stress and its assembly has been considered a key process in initiating inflammation. We have identified the well-known signaling molecule Bruton’s Tyrosine Kinase (BTK) as an unexpected but prominent regulator of NLRP3 inflammasome activity in both mice and humans. The discovery of BTK as an NLRP3 regulator offers the unique opportunity to target the NLRP3 inflammasome at the level of a well-known pharmacological target, BTK, via efficacious and well-tolerated FDA-approved inhibitors, e.g. ibrutinib (PCI-32765). For doing so, the mechanistic molecular and the cellular role of BTK in inflammasome activation needs to be more comprehensively studied, which is the goal of this present project. Our vision is to elucidate the molecular workings of the BTK-NLRP3 inflammasome to a level that will allow for safely harnessing the considerable translational potential of BTK as a targetable NLRP3 regulator.
Suggested reading

Suggested reading

Liu, …, Weber J Allergy Clin Immunol 2017: Human NACHT, LRR, and PYD domain-containing protein (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase

Weber et al., Frontiers Immunol 2017: Bruton’s Tyrosine Kinase: An Emerging Key Player in Innate Immunity

Henrickson Science Immunol 2017: Teaching an old pathway new tricks: Targeting BTK to block NLRP3 (comment).

Methods and skills to learn

Standard immunology techniques (PBMC preparation, cell culture assays of cell lines and primary human and mouse immune cells, ELISA, flow cytometry), standard molecular biology (mutagenesis, PCR, restriction digests, sub-cloning), standard protein biochemistry (SDS-PAGE, immunoblot, immunoprecipitation, chromatography), reporter signaling assays, data analysis, scientific writing and presentation.

The team

In order to execute this project and complement our laboratory team we hope to recruit additional excellent and enthusiastic researchers, including one PhD student. You would be part of a dynamic research group with a solid track record, and located in an excellent scientific environment, the Department of Immunology located on the campus of the University of Tübingen, one of Germany’s Excellence Universities. In our well-funded laboratory you would find a friendly, well-connected and international (English-speaking) environment, and a firm commitment to good supervision and professional development.

Your application profile:

Masters degree (or equivalent) in biological sciences or medicine, some research experience in molecular/cellular biology, microbiology/virology, protein biochemistry and/or immunology; high motivation to work independently and as part of a team; good command of the English language (written and spoken); both German and international applications encouraged and international applicants will be supported to attend German courses but German skills are not required to apply successfully.

Your application

Please apply electronically to [Email Address Removed] with all of the following: Cover/motivation letter (max 1 A4), CV, transcripts and certificate of MSc and BSc degree, support letter from at least 1 previous supervisor. Applications will be reviewed on an ongoing basis and interviews scheduled accordingly.


Funding Notes

Starts Spring 2019, Duration: 3 years, Remuneration: DFG-funded German TV-L E13 65% position. Application open NOW

References

Liu, …, Weber J Allergy Clin Immunol 2017: Human NACHT, LRR, and PYD domain-containing protein (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase

Weber et al., Frontiers Immunol 2017: Bruton’s Tyrosine Kinase: An Emerging Key Player in Innate Immunity

Henrickson Science Immunol 2017: Teaching an old pathway new tricks: Targeting BTK to block NLRP3 (comment).